Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, James I. Mullins, Chivonne Moodley et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention TrialsCarolyn Williamson, James I. Mullins, Craig A. Magaret et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1